Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Epilepsy Research

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0920-1211(98)00104-1PMID 10210031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.

  1998cited by this paper
• Comparison of Single‐ and Repeated‐Dose Pharmacokinetics of Diazepam

  1998cited by this paper
• Inhibition by levetiracetam of a non‐GABAA receptor‐associated epileptiform effect of bicuculline in rat hippocampus

  1997cited by this paper
• Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain.

  1997cited by this paper
• The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.

  1996cited by this paper
• Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy

  1996cited by this paper
• A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb LO59) in serum or plasma by high performance liquid chromatography.

  1996cited by this paper
• Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam.

  1996cited by this paper
• Clinical pharmacokinetics of new antiepileptic drugs.

  1995cited by this paper
• Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy.

  1995cited by this paper
• Occipital Paroxysmal Discharges Suppressed By Eye Opening: Variability in Clinical and Seizure Manifestations in Childhood

  1995cited by this paper
• ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo.

  1995cited by this paper
• The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes.

  1995cited by this paper
• Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin.

  1994cited by this paper
• Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats.

  1993cited by this paper
• Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide

  1993cited by this paper
• ucb L059, a novel anti-convulsant drug: pharmacological profile in animals.

  1992cited by this paper
• A freely moving and behaving rat model for the chronic and simultaneous study of drug pharmacokinetics (blood) and neuropharmacokinetics (cerebrospinal fluid): hematological and biochemical characterization and kinetic evaluation using carbamazepine.

  1992cited by this paper
• Pharmacokinetic modeling of the anticonvulsant action of phenobarbital in rats.

  1989cited by this paper
• Kinetics of drug action in disease states. XXIV. Pharmacodynamics of diazepam and its active metabolites in rats.

  1988cited by this paper
• Concurrent monitoring of central carbamazepine and transmitter amine metabolism and motor activity in individual unrestrained rats using repetitive withdrawal of cerebrospinal fluid.

  1988cited by this paper
• JANA: a new iterative polyexponential curve stripping program.

  1985cited by this paper
• Kinetics of drug action in disease states. I. Effect of infusion rate on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex.

  1984cited by this paper

• Phylogenetic divergence of GABAB receptor signaling in neocortical networks over adult life

  2025cites this paper
• Pharmacokinetic and pharmacodynamic data from the NEOLEV1 and NEOLEV2 studies

  2024cites this paper
• Interspecies Brain PBPK Modeling Platform to Predict Passive Transport through the Blood–Brain Barrier and Assess Target Site Disposition

  2024cites this paper
• Levetiracetam and Midazolam vs Midazolam Alone for First-Line Treatment of Children With Generalized Convulsive Status Epilepticus (Lev-Mid Study): A Randomized Controlled Trial

  2023cites this paper
• Temporal relationship between levetiracetam nonadherence and breakthrough seizures in a preclinical model of temporal lobe epilepsy

  2023cites this paper
• Treatment of Status Epilepticus after Traumatic Brain Injury Using an Antiseizure Drug Combined with a Tissue Recovery Enhancer Revealed by Systems Biology

  2023cites this paper
• Discovery of E2730, a novel selective uncompetitive GAT1 inhibitor, as a candidate for anti‐seizure medication

  2023cites this paper
• Levetiracetam Mechanisms of Action: From Molecules to Systems

  2022cites this paper
• Levetiracetam promoted rat embryonic neurogenesis via NMDA receptor-mediated mechanism in vitro.

  2021cites this paper
• Pharmacokinetics of levetiracetam in neurosurgical ICU patients.

  2021cites this paper
• Early intervention with levetiracetam prevents the development of cortical hyperexcitability and spontaneous epileptiform activity in two models of neurotrauma in rats.

  2020cites this paper
• Circulating concentrations of levetiracetam in patients treated for status epilepticus and assocation with therapeutic response

  2019cites this paper
• Pharmacokinetics of a commercially available product and a compounded formulation of extended-release levetiracetam after oral administration of a single dose in cats.

  2019cites this paper
• Reduced firing rates of pyramidal cells in frontal cortex of APP/PS1 can be restored by acute treatment with levetiracetam

  2019cites this paper
• [Levetiracetam for treatment of status epilepticus - an update].

  2019cites this paper
• Bioanalytical tools for unraveling part of the puzzle of the biochemical phenomena in epilepsy: neuromediators and antiepileptic drugs

  2019cites this paper
• Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model.

  2019cites this paper
• What goes up must come down: homeostatic synaptic plasticity strategies in neurological disease.

  2018cites this paper
• Pyridoxine Add-On Treatment for the Control of Behavioral Adverse Effects Induced by Levetiracetam in Children: A Case-Control Prospective Study

  2018cites this paper
• Levetiracetam circulating concentrations and response in status epilepticus.

  2018cites this paper
• Pharmacokinetics of the anticonvulsant levetiracetam in neonatal foals

  2018cites this paper
• Disposition of levetiracetam in healthy adult horses

  2018cites this paper
• Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy

  2018cites this paper
• Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents

  2017cites this paper
• Refractory Status Epilepticus

  2017influential citation
• Levetiracetam monotherapy for treatment of structural epilepsy in dogs: 19 cases (2010–2015)

  2017cites this paper
• First HPLC method for the simultaneous quantification of levetiracetam, zonisamide, lamotrigine, pentylenetetrazole and pilocarpine in rat plasma and brain

  2017cites this paper
• Drugs Commonly Used to Treat Refractory Status Epilepticus in Clinical Practice

  2017cites this paper
• Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial.

  2016cites this paper
• Add-on Levetiracetam in Children With Refractory Epilepsy: A Systematic Review

  2016cites this paper
• Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain.

  2016influential citation
• Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action

  2016cites this paper
• Levetiracetam for the treatment of status epilepticus

  2015cites this paper
• Intramuscular and rectal therapies of acute seizures.

  2015cites this paper
• Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review

  2015cites this paper
• Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy

  2015cites this paper
• Pharmacokinetics of Levetiracetam in Healthy Hispaniolan Amazon Parrots (Amazona ventralis) After Oral Administration of a Single Dose

  2014cites this paper
• UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO

  2014cites this paper
• Structure activity relationships of novel antiepileptic drugs.

  2014cites this paper
• Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice

  2014cites this paper
• Translational Investigations of Rewarding Substances Using the Curve-Shift Method of Intracranial Self-Stimulation in Mice

  2014cites this paper
• A simple assay for determination of levetiracetam in rat dried blood spots by LC-MS/MS.

  2013cites this paper
• Levetiracetam Has Opposite Effects on Alcohol- and Cocaine-Related Behaviors in C57BL/6J Mice

  2013cites this paper
• The Antiepileptic Drug Levetiracetam Suppresses Non-Convulsive Seizure Activity and Reduces Ischemic Brain Damage in Rats Subjected to Permanent Middle Cerebral Artery Occlusion

  2013cites this paper
• Pharmacological and neuroethological studies of three antiepileptic drugs in the Genetic Audiogenic Seizure Hamster (GASH:Sal).

  2013cites this paper
• Lewetiracetam i leczenie padaczki w szczególnych sytuacjach klinicznych

  2013cites this paper
• A simple assay for determination of levetiracetam in rat dried blood spots by

  2013cites this paper
• Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.

  2012cites this paper
• Characteristics of selected second-generation antiepileptic drugs used in dogs.

  2012influential citation
• Strategies to improve the killing of tumors using temozolomide: targeting the DNA repair protein MGMT.

  2012cites this paper
• Bioequivalence of a Novel Minitablet Formulation of Levetiracetam

  2012cites this paper
• A “Magic Shotgun” Perspective on Anticonvulsant Mechanisms

  2012cites this paper
• Injectable Levetiracetam Use In the Dog A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Brian Thomas Hardy IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE

  2012cites this paper
• levetiracetamentry may mediate the effects of A new mechanism for antiepileptic drug action

  2011cites this paper
• IDENTIFYING THE MECHANISM OF ACTION OF THE ANTIEPILEPTIC DRUG LEVETIRACETAM IN SYNAPTIC VESICLE RELEASE AND ITS IMPLICATIONS FOR EPILEPSY

  2011cites this paper
• Identifying the mechanism of action of the antiepileptic drug levetiracetam in synaptic vesicle release and its implications for epilepsy.

  2011cites this paper
• A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.

  2011cites this paper
• Pharmacokinetics of levetiracetam after oral and intravenous administration of a single dose to clinically normal cats.

  2011cites this paper
• Levetiracetam: a comprehensive review

  2010cites this paper
• Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats.

  2010cites this paper
• Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide.

  2010cites this paper
• Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies.

  2010cites this paper
• Inhibitory effects of levetiracetam on absence seizures in a novel absence-like epilepsy animal model, Groggy rat.

  2010cites this paper
• Effects of levetiracetam on blood-brain barrier disturbances following hyperthermia-induced seizures in rats with cortical dysplasia.

  2010cites this paper
• Levetiracetam: a comprehensive review.

  2010cites this paper
• Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.

  2009cites this paper
• The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs.

  2008cites this paper
• HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam.

  2008cites this paper
• Levetiracetam prevents kindling‐induced asymmetric accumulation of hippocampal 7S SNARE complexes

  2008cites this paper
• Levetiracetam and Felbamate Interact Both Pharmacodynamically and Pharmacokinetically: An Isobolographic Analysis in the Mouse Maximal Electroshock Model

  2007cites this paper
• Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.

  2007cites this paper
• Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects.

  2007cites this paper
• Novel anticonvulsant drugs.

  2007cites this paper
• Levetiracetam Reduces Anesthetic-Induced Hyperalgesia in Rats

  2007cites this paper
• The Pharmacokinetics of Antiepileptic Drugs in Rats: Consequences for Maintaining Effective Drug Levels during Prolonged Drug Administration in Rat Models of Epilepsy

  2007cites this paper
• Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures

  2006cites this paper
• Levetiracetam: Antiepileptic Properties and Protective Effects on Mitochondrial Dysfunction in Experimental Status Epilepticus

  2006cites this paper
• Einfluss von Levetiracetam und Topiramat auf den intrazellulären pH-Wert und die bioelektrische Aktivität hippocampaler CA3-Neurone des Meerschweinchens

  2005cites this paper
• Separation of Antiepileptogenic and Antiseizure Effects of Levetiracetam in the Spontaneously Epileptic Rat (SER)

  2005cites this paper
• Long‐lasting Antiepileptic Effects of Levetiracetam against Epileptic Seizures in the Spontaneously Epileptic Rat (SER): Differentiation of Levetiracetam from Conventional Antiepileptic Drugs

  2005cites this paper
• Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog

  2004cites this paper
• Clinical Pharmacokinetics of Levetiracetam

  2004cites this paper
• Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with Levetiracetam.

  2003cites this paper
• The pharmacokinetic characteristics of levetiracetam.

  2003cites this paper
• LEVETIRACETAM: A NEW THERAPEUTIC OPTION FOR REFRACTORY EPILEPSY

  2003cites this paper
• Determination of antiepileptic drugs in biological material.

  2002cites this paper
• Effect of Levetiracetam on Epileptiform Discharges in Human Neocortical Slices

  2002cites this paper
• [Pharmacological treatment of epilepsies: progress during the last 10 years].

  2002cites this paper
• A comparison of the efficacy of carbamazepine and the novel anti‐epileptic drug levetiracetam in the tetanus toxin model of focal complex partial epilepsy

  2002cites this paper
• Levetiracetam: A Different Approach to the Pharmacotherapy of Epilepsy

  2002cites this paper
• Antikonvulsive Pharmakotherapie: Entwicklung in den letzten 10 Jahren

  2002cites this paper
• A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain

  2001influential citation
• Effect of levetiracetam on human corticospinal excitability

  2001cites this paper
• Pharmacokinetics of Levetiracetam and Its Enantiomer (R)‐α‐ethyl‐2‐oxo‐pyrrolidine acetamide in Dogs

  2001cites this paper
• An assessment of levetiracetam as an anti-epileptic drug

  2000cites this paper
• Pharmacokinetic profile of levetiracetam: toward ideal characteristics.

  2000cites this paper
• Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine

  2000influential citation
• The Next Wave of Anticonvulsants

  2000cites this paper
• Blood and cerebrospinal fluid pharmacokinetics of primidone and its primary pharmacologically active metabolites, phenobarbital and phenylethylmalonamide in the rat

  1999cites this paper
• Simple and routinely affordable method for therapeutic monitoring of Levetiracetam : A comparison to often applied HPLC method

  year unknowncites this paper